In a decision that surprised Wall Street analysts, Teladoc Health announced that long-time CEO Jason Gorevic will depart the company immediately.
In a statement, the board of directors said, CFO Mala Murthy will take over as the acting chief executive.
The leadership change comes as the virtual care company hunts for a path forward after a period of explosive growth during the Covid-19 pandemic. In February the company projected it would see single-digital growth for the next several years. Teladoc shares are down from its 2021 high of around $294, with the stock currently trading at around $14 a share.
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect